Phil Bonomi, MD of Rush University Medical Center discusses whether or not MET inhibitors are effective in the treatment of metastatic non-small cell lung cancer. This was recorded at the 2017 Annual Meeting Annual Meeting in Chicago, IL.
Advertisement
Advertisement